KeyBank National Association’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Hold
10,040
﹤0.01% 561
2025
Q1
$1.25M Buy
10,040
+4
+0% +$497 0.01% 508
2024
Q4
$1.24M Hold
10,036
﹤0.01% 516
2024
Q3
$1.12M Buy
10,036
+3
+0% +$334 ﹤0.01% 538
2024
Q2
$1.07M Sell
10,033
-34
-0.3% -$3.63K ﹤0.01% 521
2024
Q1
$1.21M Sell
10,067
-736
-7% -$88.6K 0.01% 490
2023
Q4
$1.33M Buy
10,803
+731
+7% +$89.9K 0.01% 455
2023
Q3
$1.3M Sell
10,072
-18
-0.2% -$2.33K 0.01% 423
2023
Q2
$1.25M Buy
10,090
+18
+0.2% +$2.23K 0.01% 443
2023
Q1
$1.47M Hold
10,072
0.01% 413
2022
Q4
$1.6M Sell
10,072
-6
-0.1% -$956 0.01% 389
2022
Q3
$1.34M Sell
10,078
-1
-0% -$133 0.01% 404
2022
Q2
$1.57M Buy
+10,079
New +$1.57M 0.01% 391
2020
Q2
Sell
-2,262
Closed -$226K 960
2020
Q1
$226K Sell
2,262
-107
-5% -$10.7K ﹤0.01% 829
2019
Q4
$354K Buy
2,369
+42
+2% +$6.28K ﹤0.01% 816
2019
Q3
$298K Sell
2,327
-2,892
-55% -$370K ﹤0.01% 840
2019
Q2
$744K Sell
5,219
-4,049
-44% -$577K ﹤0.01% 631
2019
Q1
$1.33M Sell
9,268
-8,237
-47% -$1.18M 0.01% 434
2018
Q4
$2.17M Buy
17,505
+14,566
+496% +$1.81M 0.01% 332
2018
Q3
$494K Buy
2,939
+131
+5% +$22K ﹤0.01% 768
2018
Q2
$484K Buy
+2,808
New +$484K ﹤0.01% 748